$374.28
-3.35-0.89%
Last update: Oct 26, 9:36 AM
BeOne Medicines Ltd (ONC) Stock Price, Quote, News & History
ONCNASDAQ
FDA approves Jazz Pharmaceuticals' Ziihera combinations for first-line treatment of HER2-positive gastroesophageal adenocarcinoma.
You can purchase shares of BeOne Medicines (NASDAQ:ONC) through any online brokerage.
Other companies in BeOne Medicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BeOne Medicines has a consensus price target of $387.40.
The stock price for BeOne Medicines (NASDAQ: ONC) is $374.28 last updated October 26, 2026 at 9:36 AM EDT.
There are no upcoming dividends for BeOne Medicines.
BeOne Medicines does not have any upcoming earnings scheduled.
There is no upcoming split for BeOne Medicines.
BeOne Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of non-Hodgkin...
